AstraZeneca(AZN) - 2024 Q4 - Earnings Call Transcript

AstraZeneca PLC (NASDAQ:AZN) Q4 2024 Earnings Conference Call February 6, 2025 6:00 AM ET Company Participants Pascal Soriot – Executive Director and Chief Executive Officer Iskra Reic – Executive Vice President-International Aradhana Sarin – Executive Director and Chief Financial Officer Dave Fredrickson – Executive Vice-President-Oncology Business Unit Susan Galbraith – Executive Vice President-Oncology R&D Ruud Dobber – Executive Vice President-BioPharmaceuticals Business Unit Sharon Barr – Executive Vic ...